Elevatus财富管理公司将AbbVie的股份增加84.8%,获得价值455 000美元的股份。 Elevatus Wealth Management boosts AbbVie holdings by 84.8%, acquiring $455,000 worth of shares.

Elevatus财富管理投资公司在AbbVie Inc.的股份大幅增加了84.8%,获得了1 175个额外股份,现在共有2 560个股份,价值455 000美元。 Investment firm Elevatus Wealth Management significantly increased its holdings in AbbVie Inc. by 84.8%, acquiring 1,175 additional shares, now totaling 2,560 shares valued at $455,000. AbbVie,一个制药巨头,为诸如自发免疫疾病、皮丝虫病和血癌等疾病开发治疗方法。 AbbVie, a pharmaceutical giant, develops treatments for conditions such as autoimmune diseases, psoriasis, and blood cancers. 尽管最近一份收入报告显示EPS低于分析师的预期,但AbbVie的股本回报率很高,市场存在强劲,市场上限为3 056.4亿美元,股息收益率为3.80%。 Despite a recent earnings report showing EPS below analyst expectations, AbbVie maintains a high return on equity and strong market presence, with a market cap of $305.64 billion and a 3.80% dividend yield.